Form 4 for ACRV Acrivon Therapeutics, Inc.
Accepted 2024-10-03 00:00:00 ET · period of report 2024-10-01 · accession 0000905148-24-002637 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-03 | 2024-10-01 | ACRV | Miller Mary | CLO | F - Tax | $6.98 | -284 | 38.7K | -0.7% | -$1,982 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-01 | F | D | 284 | $6.98 | 38,683 | D | — | — |